| Mrs Janet Wilson, LCPC | |
|
6826 Lackman Rd, Shawnee, KS 66217-9595 | |
| (913) 486-4111 | |
| Not Available |
| Full Name | Mrs Janet Wilson |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 6826 Lackman Rd, Shawnee, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386981017 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 725 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Janet Wilson, LCPC 7843 Orville Ave, Kansas City, KS 66112-2632 Ph: (913) 486-4111 | Mrs Janet Wilson, LCPC 6826 Lackman Rd, Shawnee, KS 66217-9595 Ph: (913) 486-4111 |
News Archive
Gordon and Landman have authored a Perspective piece in the New England Journal of Medicine that addresses the growing threat of attacks on information systems and the potential implications on public health.
Parents with a child requiring stem cell transplantation can have genetic testing done on embryos prior to implantation to determine if the tissue type matches and the ensuing offspring could potentially serve as a donor to the affected child, according to a study in the May 5 issue of The Journal of the American Medical Association (JAMA).
COVID-19 has been associated with increases in opioid overdose deaths, which may be in part because the pandemic limited access to buprenorphine, a treatment used for opioid dependency, according to a new study led by Princeton University researchers.
TenX Biopharma, Inc. announced today that data from a Phase II trial of zanolimumab (HuMax-CD4®) in peripheral T-cell Lymphoma were published in the British Journal of Haematology (Sep 2010: 150(5):565-73). The Hx-CD4-109 trial was designed to evaluate the safety and efficacy of zanolimumab in patients who have relapsed or refractory non-cutaneous peripheral T-cell lymphoma.
Between 5 % and 10 % of breast cancer cases are hereditary, arising because the patient inherits from the father or mother a mutation in a gene that is susceptible to causing the illness. BRCA1 and BRCA2 have already been identified as two of the genes to be monitored. It is estimated that 30 % of hereditary breast cancer cases are due to mutations in one of these two genes.
› Verified 4 days ago
Jennifer Melby, LPC Counselor Medicare: Medicare Enrolled Practice Location: 6440 Nieman Rd, Shawnee, KS 66203 Phone: 913-826-4200 | |
Douglas Johnson, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6221 Richards Dr, Shawnee, KS 66216 Phone: 913-248-1943 Fax: 913-248-1994 | |
Kevin Ryan Kufeldt, LPC Counselor Medicare: Medicare Enrolled Practice Location: 6440 Nieman Rd, Shawnee, KS 66203 Phone: 913-826-4200 | |
Alexandria Wagner, LPC Counselor Medicare: Medicare Enrolled Practice Location: 6440 Nieman Rd, Shawnee, KS 66203 Phone: 913-826-4200 | |
Kristy Mccollum-wachter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 11120 W 65th St, Shawnee, KS 66203 Phone: 913-826-4200 | |
Sue Jacobson, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6221 Richards Dr, Shawnee, KS 66216 Phone: 913-248-1943 Fax: 913-248-1994 | |
Fatemeh Mohammadzadeh, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6840 Silverheel St, Shawnee, KS 66226 Phone: 913-647-7709 |